{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:27Z","timestamp":1794270147337,"version":"4.9.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004433","name":"Chinese Pharmaceutical Association","doi-asserted-by":"publisher","award":["CPA-Z05-ZC-2025-003"],"award-info":[{"award-number":["CPA-Z05-ZC-2025-003"]}],"id":[{"id":"10.13039\/501100004433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["99106247"],"award-info":[{"award-number":["99106247"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107962","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:19:54Z","timestamp":1786637994000},"page":"107962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic drug monitoring of aztreonam-avibactam in critically ill patients with CRKP infections and variable renal function: A case series"],"prefix":"10.1016","volume":"67","author":[{"given":"Guanghui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-2450","authenticated-orcid":false,"given":"Jian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107962_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.114782","article-title":"Carbapenem resistance and hypervirulence in Klebsiella pneumoniae are raising global public health concerns in the 21(st) century","volume":"29","author":"Thacharodi","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0002","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2024.02.023","article-title":"Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors","volume":"80","author":"Martin-Mateos","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40265-025-02258-x","article-title":"Aztreonam-avibactam: a review in the treatment of serious bacterial infections caused by aerobic gram-negative organisms","volume":"86","author":"Shirley","year":"2026","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0004","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/phar.4629","article-title":"Aztreonam-avibactam: the dynamic duo against multidrug-resistant gram-negative pathogens","volume":"44","author":"Al Musawa","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0005","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1093\/jac\/dkaf330","article-title":"Pharmacokinetics of aztreonam\/avibactam in a critically ill patient with a class B metallo-\u03b2-lactamase producing Enterobacteriaceae and receiving continuous renal replacement therapy","volume":"80","author":"Fres\u00e1n","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.ijantimicag.2026.107962_bib0006","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/antibiotics11121769","article-title":"Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review","volume":"11","author":"Corona","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0007","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/jac\/dkaf177","article-title":"An ex vivo model to determine transmembrane clearance of antimicrobials during continuous renal replacement therapy","volume":"80","author":"McGrath","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107962_bib0009","doi-asserted-by":"crossref","first-page":"e02446","DOI":"10.1128\/AAC.02446-17","article-title":"Avibactam Pharmacokinetic\/Pharmacodynamic Targets","volume":"62","author":"Nichols","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0010","unstructured":"EMA. Human medicine european public assessment report (EPAR): emblaveo. 2024. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/emblaveo."},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0011","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2026"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0012","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters, version 16.0. 2026. Available at: https:\/\/www.eucast.org\/fileadmin\/eucast\/pdf\/breakpoints\/v_16.0_Breakpoint_Tables.pdf."},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081284","article-title":"Strategies and tactics to reduce the impact of healthcare on climate change: systematic review","volume":"387","author":"Braithwaite","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2026.107962_bib0014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MAT.0000000000002387","article-title":"Comparison of different membranes for continuous renal replacement therapies: an In vitro study","volume":"71","author":"Malard","year":"2025","journal-title":"ASAIO J"},{"issue":"8","key":"10.1016\/j.ijantimicag.2026.107962_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01950-24","article-title":"Population pharmacokinetic\/pharmacodynamic modeling to optimize aztreonam-avibactam dose regimens for adult patients","volume":"69","author":"Xie","year":"2025","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:38:32Z","timestamp":1794267512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002499"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107962","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic drug monitoring of aztreonam-avibactam in critically ill patients with CRKP infections and variable renal function: A case series","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107962"}}